Eapen, Mathew Suji
Hansbro, Philip M.
Larsson‑Callerfelt, Anna-Karin
Jolly, Mohit K.
Myers, Stephen
Sharma, Pawan
Jones, Bernadette
Rahman, Md Atiqur
Markos, James
Chia, Collin
Larby, Josie
Haug, Greg
Hardikar, Ashutosh
Weber, Heinrich C.
Mabeza, George
Cavalheri, Vinicius
Khor, Yet H.
McDonald, Christine F.
Sohal, Sukhwinder Singh
Funding for this research was provided by:
Clifford Craig Foundation Launceston (143, 153, 171)
Cancer Council Western Australia
TSANZ Boehringer Ingelheim COPD Research Award (S26084)
Gulf Coast Consortia, on the Computational Cancer Biology Training Program
Rebecca L. Cooper Medical Research Foundation
Chancellors Fellowship Programme, University of Technology Sydney
Article History
First Online: 3 November 2018
Compliance with Ethical Standards
:
: Mathew Suji Eapen, Anna-Karin Larsson‑Callerfelt, Mohit K. Jolly, Stephen Myers, Pawan Sharma, Bernadette Jones, Md Atiqur Rahman, James Markos, Collin Chia, Josie Larby, Greg Haug, Ashutosh Hardikar, Heinrich C. Weber, George Mabeza and Vinicius Cavalheri declare no conflicts of interest. Sukhwinder Singh Sohal reports grants from the Thoracic Society of Australia and New Zealand (TSANZ), Boehringer Ingelheim and the Clifford Craig Foundation. Philip M. Hansbro has no conflicts of interest related to this manuscript, aside from the fact that this article relates to mouse models of lung cancer and COPD, which we regularly use. Yet H. Khor reports grants from the National Health and Medical Research Council and Boehringer Ingelheim, and non-financial support from Air Liquide, as well as honorarium from Boehringer Ingelheim, Roche and Astra Zeneca, outside the submitted work. Christine F. McDonald has received speakers fees from, and participated in advisory boards for, GSK, Pfizer and Novartis, and has donated speaker fees from Menarini to her hospital.
: The preparation of this review was not supported by any external funding.